GlaxoSmithKline Pharma net jumps by 46% to Rs 194 cr in Q4
GlaxoSmithKline Pharmaceutical (GSK), a leading multinational pharma entity, has posted satisfactory financial performance during the fourth quarter ended March 2024 with double digit revenue growth. The company’s net profit increased by 45.9 per cent to …